Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for ...

On remand from the Federal Circuit, the Patent Trial and Appeal Board on Thursday reaffirmed its decision that The Broad ...

CRISPR is a powerful DNA-editing tool that has underpinned huge advancements in human health care in the last decade. It is a ...

In a decision announced today (March 26), the U.S. Patent and Trademark Office's Patent Trial and Appeal Board (USPTO and ...

A standing committee of Parliament on Agriculture has called for 100 per cent procurement of oilseeds and pulses at the minimum support price (MSP), as against the current 25 per cent, to bring down ...

Scientists have developed a breakthrough “superfood” for honeybees by engineering yeast to produce the essential nutrients normally found in pollen. In controlled trials, colonies fed this specially ...

In a world-first experiment, scientists in Germany have used CRISPR-Cas9 to create genetically modified spiders that spin red ...

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that the ...

A parliamentary panel has recommended setting up a regulatory body to fix seed prices in India, stressed the urgent need for ...

A new technique may reprogram immune cells inside the body, offering faster, simpler, and more accessible cancer treatment.

Researchers have built a series of CRISPR-based platforms that can switch endogenous genes on and, just as critically, dial ...